Cancer Therapy News and Research

RSS
Treatment with biosimilar drug improves progression-free survival in breast cancer patients

Treatment with biosimilar drug improves progression-free survival in breast cancer patients

Novel imaging technique shows promise to detect, monitor and guide therapy for prostate cancer

Novel imaging technique shows promise to detect, monitor and guide therapy for prostate cancer

Type 2 diabetes drug may someday help combat breast and ovarian cancers

Type 2 diabetes drug may someday help combat breast and ovarian cancers

NUS study offers new hope for treating aggressive ovarian cancer subtype

NUS study offers new hope for treating aggressive ovarian cancer subtype

New green nanotechnology approach targets, destroys precancerous tumor cells in livers of mice

New green nanotechnology approach targets, destroys precancerous tumor cells in livers of mice

Study shows heart medications prevent cardiovascular damage during breast cancer treatment

Study shows heart medications prevent cardiovascular damage during breast cancer treatment

Kratom may be safer and less addictive than current treatments for pain, research suggests

Kratom may be safer and less addictive than current treatments for pain, research suggests

Researchers engineer cells with 'built-in genetic circuit' that can inhibit tumour growth

Researchers engineer cells with 'built-in genetic circuit' that can inhibit tumour growth

Cancer experts to discuss novel treatment strategies at ESMO Asia 2016 Congress

Cancer experts to discuss novel treatment strategies at ESMO Asia 2016 Congress

Researcher to examine if music intervention can alleviate distress in young cancer patients and parents

Researcher to examine if music intervention can alleviate distress in young cancer patients and parents

TSRI scientists offer novel structure-based drug design strategy for better breast cancer treatment

TSRI scientists offer novel structure-based drug design strategy for better breast cancer treatment

Weight loss programs can help breast cancer survivors reduce risk of recurrence

Weight loss programs can help breast cancer survivors reduce risk of recurrence

Drug combination therapy delays progression of advanced breast cancer without side effects, study shows

Drug combination therapy delays progression of advanced breast cancer without side effects, study shows

Veterans Affairs researchers discover alleles of certain genes that offer protection from GWI

Veterans Affairs researchers discover alleles of certain genes that offer protection from GWI

Tumour cell of origin in childhood malignant glioma impacts susceptibility to cancer therapy

Tumour cell of origin in childhood malignant glioma impacts susceptibility to cancer therapy

Researchers developing biomaterial with potential to treat vascular bleeding

Researchers developing biomaterial with potential to treat vascular bleeding

New guidelines provide recommendations on HER2 testing for patients with gastroesophageal cancers

New guidelines provide recommendations on HER2 testing for patients with gastroesophageal cancers

Fraunhofer researchers use new deep learning approach to facilitate tumor measurement

Fraunhofer researchers use new deep learning approach to facilitate tumor measurement

Study finds long-term use of transdermal opioid patches twice as common among Alzheimer's patients

Study finds long-term use of transdermal opioid patches twice as common among Alzheimer's patients

Virginia Tech and CytImmune Sciences develop more effective and less toxic cancer treatment

Virginia Tech and CytImmune Sciences develop more effective and less toxic cancer treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.